title: [Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists therapy for choroidal neovascularization in myopia ].
authors.affiliation: Augenabteilung, St. Franziskus Hospital, Münster.
authors.forename: D
authors.initials: D
authors.lastname: Pauleikhoff
authors.affiliation: Augenarztpraxis, Köln.
authors.forename: B
authors.initials: B
authors.lastname: Bertram
authors.affiliation: Augenarztpraxis, Aachen.
authors.forename: D
authors.initials: D
authors.lastname: Claessens
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D020256:Choroidal Neovascularization / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D019317:Evidence-Based Medicine; D005858:Germany; D006801:Humans; D009216:Myopia / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D009885:Ophthalmology / Q000592:standards*; D010778:Photochemotherapy / Q000592:standards*; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
chemical_list: D020533:Angiogenesis Inhibitors; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A